HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Masato Nishimura Selected Research

Nicorandil (SG 75)

4/2015Improvement of myocardial fatty acid metabolism by oral nicorandil in hemodialysis patients without coronary artery disease.
1/2014Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
1/2011Oral nicorandil for prevention of cardiac death in hemodialysis patients without obstructive coronary artery disease: a propensity-matched patient analysis.
8/2009Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
1/2009Clinical potential of nicorandil to inhibit major cardiac events in hemodialysis patients with suspected myocardial ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Masato Nishimura Research Topics

Disease

17Neoplasms (Cancer)
11/2015 - 09/2008
10Coronary Artery Disease (Coronary Atherosclerosis)
01/2016 - 08/2004
9Death (Near-Death Experience)
09/2015 - 01/2008
8Ovarian Neoplasms (Ovarian Cancer)
01/2015 - 08/2010
7Chronic Kidney Failure (Chronic Renal Failure)
08/2011 - 09/2003
5Carcinoma (Carcinomatosis)
01/2014 - 11/2010
4Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 12/2008
4Coronary Stenosis (Coronary Artery Stenosis)
09/2011 - 09/2005
4Insulin Resistance
08/2011 - 06/2006
4Diabetes Mellitus
04/2011 - 09/2003
3Myocardial Ischemia (Ischemic Heart Diseases)
03/2013 - 01/2008
2Heart Failure
03/2013 - 03/2002
2Neoplasm Metastasis (Metastasis)
04/2011 - 11/2010
2Myocardial Infarction
01/2009 - 06/2007
1Anemia
11/2015
1Left Ventricular Dysfunction
01/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2015
1Anoxia (Hypoxia)
01/2015
1Hypoalbuminemia
01/2015
1Adenocarcinoma
01/2015
1Ischemia
03/2013
1Secondary Hyperparathyroidism
09/2012
1Atrial Fibrillation
09/2012
1Hypertension (High Blood Pressure)
11/2011
1Pathologic Constriction (Stenosis)
09/2011
1Melanoma (Melanoma, Malignant)
05/2011
1Colorectal Neoplasms (Colorectal Cancer)
04/2011
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
06/2010
1Cardiac Sudden Death (Sudden Cardiac Arrest)
06/2010
1Heart Diseases (Heart Disease)
12/2008
1Hearing Loss (Hearing Impairment)
09/2006
1Vertigo (Positional Vertigo)
09/2006
1Paresis (Hemiparesis)
09/2006

Drug/Important Bio-Agent (IBA)

10iodofiltic acidIBA
01/2016 - 08/2004
7Small Interfering RNA (siRNA)IBA
11/2013 - 08/2010
5Nicorandil (SG 75)IBA
04/2015 - 01/2009
4docetaxel (Taxotere)FDA Link
01/2014 - 08/2010
3pentadecanoic acidIBA
04/2015 - 07/2006
3bevacizumabFDA Link
01/2015 - 09/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 09/2011
3Insulin (Novolin)FDA Link
08/2011 - 03/2002
2Cisplatin (Platino)FDA LinkGeneric
05/2013 - 04/2013
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2013 - 06/2007
2Angiotensin IIIBA
11/2011 - 01/2003
2HDL CholesterolIBA
08/2011 - 06/2006
2Triglycerides (Triacylglycerol)IBA
08/2011 - 06/2006
2AdiponectinIBA
08/2011 - 06/2006
1ErythropoietinFDA Link
11/2015
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2015
1TaxoidsIBA
01/2014
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2014
1Biological Markers (Surrogate Marker)IBA
01/2014
1IMC-3G3IBA
01/2014
1EphA2 ReceptorIBA
11/2013
1MicroRNAs (MicroRNA)IBA
11/2013
1RNA (Ribonucleic Acid)IBA
11/2013
1SK&F 82958 (SKF 82958)IBA
05/2013
1Dopamine Receptors (Dopamine Receptor)IBA
05/2013
1PlatinumIBA
05/2013
1Dopamine (Intropin)FDA LinkGeneric
05/2013
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
05/2013
11,2-oleoylphosphatidylcholine (DOPC)IBA
04/2013
1Serum AlbuminIBA
09/2012
1Proteoglycans (Proteoglycan)IBA
08/2012
1Hyaluronic Acid (Hyaluronan)IBA
08/2012
1Paclitaxel (Taxol)FDA LinkGeneric
08/2012
1taxaneIBA
08/2012
1Sodium Channels (Sodium Channel)IBA
11/2011
1SodiumIBA
11/2011
1AldosteroneIBA
11/2011
1IonsIBA
11/2011
1Antihypertensive Agents (Antihypertensives)IBA
11/2011
1dasatinib (BMS 354825)FDA Link
08/2011
1Phosphotransferases (Kinase)IBA
08/2011
1Hemoglobins (Hemoglobin)IBA
08/2011
1HydrogelIBA
05/2011
1ChitosanIBA
05/2011
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2011
1Focal Adhesion Protein-Tyrosine KinasesIBA
04/2011
1Proteins (Proteins, Gene)IBA
04/2011
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2011
1Scavenger Receptors (Scavenger Receptor)IBA
04/2011
1Lipoproteins (Lipoprotein)IBA
04/2011
1Messenger RNA (mRNA)IBA
11/2010
1Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2010
1Interleukin-8 (Interleukin 8)IBA
11/2010
1EphB4 ReceptorIBA
08/2010
1omega-Chloroacetophenone (Mace)IBA
01/2009
1Potassium Channels (Potassium Channel)IBA
01/2009
1Adenosine Triphosphate (ATP)IBA
01/2009
1Gentamicins (Gentamicin)FDA LinkGeneric
09/2006
1Vasopressins (Vasopressin)IBA
09/2006

Therapy/Procedure

24Renal Dialysis (Hemodialysis)
09/2015 - 09/2003
4Drug Therapy (Chemotherapy)
02/2015 - 09/2008
2Heterologous Transplantation (Xenotransplantation)
05/2013 - 11/2010
2Stents
08/2011 - 06/2006
2Oral Administration
01/2011 - 08/2009
1Parathyroidectomy
09/2012
1Injections
09/2006
1Premedication
09/2006